NCT06305962 2026-02-19177Lu-anti-PD-L1 sdAb in Metastatic Solid TumorsRadiopharm Theranostics, LtdPhase EARLY_PHASE1 Recruiting30 enrolled
NCT03228667 2026-01-14QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsImmunityBio, Inc.Phase 2 Active not recruiting40 enrolled
NCT06362369 2025-09-17A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy7 Hills Pharma, LLCPhase 1/2 Recruiting126 enrolled
NCT03935893 2025-07-10Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid CancersUniversity of PittsburghPhase 2 Recruiting240 enrolled
NCT05909995 2025-02-18Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid TumorsIncyte CorporationPhase 1 Terminated8 enrolled
NCT06034860 2024-11-01Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer TypesMolecular Templates, Inc.Phase 1 Terminated15 enrolled
NCT03652077 2021-11-15A Safety and Tolerability Study of INCAGN02390 in Select Advanced MalignanciesIncyte CorporationPhase 1 Completed40 enrolled